Benjamin Bailly

Multidisciplinary Approaches Identify Compounds that Bind to Human ACE2 or SARS-CoV-2 Spike Protein as Candidates to Block SARS-CoV-2–ACE2 Receptor Interactions

Christopher J. Day, Benjamin Bailly, Patrice Guillon et al. · mBio · 2021 · 78 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +11

The approved pediatric drug suramin identified as a clinical candidate for the treatment of EV71 infection—suramin inhibits EV71 infection <i>in vitro</i> and <i>in vivo</i>

Peijun Ren, Gang Zou, Benjamin Bailly et al. · Emerging Microbes & Infections · 2014 · 53 citations · Full text

Medicine, Infectious Diseases, Pharmacology +17

Structure-guided discovery of potent and dual-acting human parainfluenza virus haemagglutinin–neuraminidase inhibitors

Patrice Guillon, Larissa Dirr, Ibrahim M. El‐Deeb et al. · Nature Communications · 2014 · 49 citations · Full text

Life Sciences, Infectious Diseases, Medicinal Chemistry +12

Targeting human respiratory syncytial virus transcription anti-termination factor M2-1 to inhibit in vivo viral replication

Benjamin Bailly, Charles-Adrien Richard, Gajanand Sharma et al. · Scientific Reports · 2016 · 49 citations · Full text

Medicine, Infectious Diseases, Pharmacology +17

Clinical outcomes in patients with Philadelphia chromosome-positive leukemia treated with ponatinib in routine clinical practice—data from a Belgian registry

Timothy Devos, Violaine Havelange, Koen Theunissen et al. · Annals of Hematology · 2021 · 24 citations · Full text

Medicine, Oncology, Pharmacology +15